Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Koenig Sheldon L. Create: Alert

All | News | Filings
Date FiledTypeDescription
05/10/2023 4 Koenig Sheldon L. (President and CEO) has filed a Form 4 on Esperion Therapeutics, Inc.
Txns: Bought 20,000 shares @ $1.2596, valued at $25.2k
03/20/2023 4 Koenig Sheldon L. (President and CEO) has filed a Form 4 on Esperion Therapeutics, Inc.
Txns: Sold 6,999 shares @ $1.783, valued at $12.5k
03/17/2023 144 Form 144 - Report of proposed sale of securities:
03/15/2023 4 Koenig Sheldon L. (President and CEO) has filed a Form 4 on Esperion Therapeutics, Inc.
Txns: Granted 105,000 shares @ $0
Granted 445,000 options to buy @ $4.02, valued at $1.8M
03/08/2023 4 Koenig Sheldon L. (President and CEO) has filed a Form 4 on Esperion Therapeutics, Inc.
Txns: Sold 5,441 shares @ $5.056, valued at $27.5k
03/07/2023 144 Form 144 - Report of proposed sale of securities:
09/20/2022 4 Koenig Sheldon L. (President and CEO) has filed a Form 4 on Esperion Therapeutics, Inc.
Txns: Sold 3,394 shares @ $6.938, valued at $23.5k
08/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/01/2021 4 Koenig Sheldon L. (President and CEO) has filed a Form 4 on Esperion Therapeutics, Inc.
Txns: Granted 26,700 shares @ $0
05/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/15/2020 3 Koenig Sheldon L. (COO) has filed a Form 3 on Esperion Therapeutics, Inc.
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/26/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2020 4 Koenig Sheldon L. (EVP, Chief Commercial Officer) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 16,250 shares @ $0
Granted 65,000 options to buy @ $12.79, valued at $831.4k
02/04/2019 4 Koenig Sheldon L. (EVP, Chief Commercial Officer) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 25,000 shares @ $0
Granted 125,000 options to buy @ $27.1, valued at $3.4M
02/04/2019 3 Koenig Sheldon L. (EVP, Chief Commercial Officer) has filed a Form 3 on PORTOLA PHARMACEUTICALS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy